New article: Identifying obstacles hindering the conduct of academic-sponsored trials for drug repurposing on rare-diseases: an analysis of six use cases

EJP RD News

A new article entitled Identifying obstacles hindering the conduct of academic-sponsored trials for drug repurposing on rare-diseases: an analysis of six use cases has been published on September 15th. This paper, in which EJP RD members participated in, identifies hurdles in the set-up of six multinational clinical trials for drug repurposing, as use cases. Read…

EMA webinar on repurposing of authorised medicines pilot programme

News

In October 2021, the European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA) announced a pilot project to support the repurposing of medicines. To support not-for-profit organisations and academia ahead of the upcoming deadline for submission (February 28th), the EMA is hosting a « walk-in » clinic webinar on February 17th from 17.00 – 18.00 CET. The webinar will:…

Call for Members: IRDiRC Task Force on Drug Repurposing Guidebook

News

The Therapies Scientific Committee of the International Rare Diseases Research Consortium (IRDiRC) is establishing a Task Force on Drug Repurposing Guidebook to help developers (of all kinds) navigating the rare disease landscape and identifying specific tools and practices of relevance for repurposing projects. The creation of the Development Guidebook will focus on repurposing approaches, following the same successful methodology used…

Findacure’s Drug Repurposing for Rare Diseases Conference 2021

News

Findacure, a UK-based nonprofit that works in the rare disease sector, is organising its annual Drug Repurposing for Rare Diseases Conference 2021, which will be a fully online event bringing together patient groups, researchers, medical professionals and industry representatives to showcase innovative repurposing projects and encourage conversation between all members of the rare disease community. …